Explore our comprehensive coverage of mrna vaccines, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
In August 2026, medical research is defined by five converging shifts: GLP-1 oncology applications, personalized mRNA vaccines, in vivo CRISPR trials,...
Read Full Story →
BusinessmRNA-4157/V940, a personalized neoantigen therapy developed by Moderna and Merck, has demonstrated a...
Medical ResearchmRNA-4157/V940, a personalized neoantigen therapy developed by Moderna and Merck, has demonstrated a...
